Brandes Investment Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-12,897
Closed -$3.04M 152
2020
Q2
$3.04M Sell
12,897
-8,898
-41% -$2.03M 0.09% 105
2020
Q1
$4.42M Sell
21,795
-97
-0.4% -$21.2K 0.15% 93
2019
Q4
$5.28M Sell
21,892
-575
-3% -$127K 0.13% 89
2019
Q3
$4.35M Sell
22,467
-1,101
-5% -$211K 0.11% 88
2019
Q2
$4.34M Sell
23,568
-2,718
-10% -$487K 0.1% 90
2019
Q1
$4.99M Buy
26,286
+2,238
+9% +$427K 0.12% 87
2018
Q4
$4.68M Buy
24,048
+888
+4% +$173K 0.12% 90
2018
Q3
$4.8M Sell
23,160
-1,958
-8% -$386K 0.11% 90
2018
Q2
$4.64M Sell
25,118
-739
-3% -$131K 0.1% 89
2018
Q1
$4.41M Sell
25,857
-1,581
-6% -$290K 0.09% 92
2017
Q4
$4.77M Sell
27,438
-1,786
-6% -$316K 0.1% 91
2017
Q3
$5.45M Sell
29,224
-16,512
-36% -$2.93M 0.11% 90
2017
Q2
$7.88M Buy
+45,736
New +$7.44M 0.12% 89

Other funds holding AMGN

Brandes Investment Partners's AMGN Position: Q3 2020 in Review

Brandes Investment Partners sold out of Amgen (AMGN) in Q3 2020, closing a stake of 12,897 shares — an estimated $3.04M sold.

Brandes Investment Partners first reported a position in AMGN in Q2 2017 and held it in 13 quarters. The position peaked at $7.88M in Q2 2017. 2,127 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.

  • Brandes Investment Partners reported no remaining Amgen position as of Q3 2020 after selling out during the quarter.
  • Brandes Investment Partners sold 12,897 Amgen shares in Q3 2020, an estimated $3.04M.
  • Brandes Investment Partners first reported a position in Amgen in Q2 2017 and held it in 13 quarters.
  • Brandes Investment Partners's Amgen position peaked at $7.88M in Q2 2017.
  • 2,127 funds tracked by Wall St. Rank held Amgen as of Q3 2020.

Based on Brandes Investment Partners's 13F filing for Q3 2020, filed 12 Nov 2020.